HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yaron Tomer Selected Research

HLA-DR3 Antigen (HLA DR3 Antigen)

1/2020Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease.
12/2009Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective.
2/2008The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology.
4/2006Possible interaction between HLA-DRbeta1 and thyroglobulin variants in Graves' disease.
6/2004Analysis of HLA genes in families with autoimmune diabetes and thyroiditis.
12/2003Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease.
7/2002The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): results of studies in HLA-DR3 positive AITD families.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yaron Tomer Research Topics

Disease

19Graves Disease (Basedow Disease)
10/2021 - 07/2002
19Thyroid Diseases (Thyroid Disease)
01/2020 - 01/2002
18Thyroiditis
10/2021 - 06/2003
11Infections
01/2020 - 12/2007
9Autoimmune Thyroiditis (Lymphomatous Thyroiditis)
01/2020 - 06/2003
8Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021 - 09/2010
6Autoimmune Diseases (Autoimmune Disease)
12/2020 - 01/2007
5Virus Diseases (Viral Diseases)
01/2020 - 08/2014
5Hepatitis C
01/2015 - 04/2006
5Genetic Predisposition to Disease (Genetic Predisposition)
08/2010 - 12/2002
4COVID-19
11/2021 - 01/2020
4Chronic Hepatitis C
01/2015 - 12/2007
3Thyrotoxicosis
03/2021 - 04/2006
3Cardiac Arrhythmias (Arrythmia)
12/2009 - 04/2006
2Hypothyroidism
11/2015 - 04/2006
2Graves Ophthalmopathy
11/2008 - 03/2008
1Hyperglycemia
11/2021
1Lung Neoplasms (Lung Cancer)
03/2021
1Obesity
10/2020
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
11/2018
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2018
1Rheumatoid Arthritis
11/2018
1Hashimoto Disease (Thyroiditis, Hashimoto)
10/2018
1Autoimmune Polyendocrinopathies (Schmidt Syndrome)
02/2015
1Hyperthyroidism
06/2013
1Inflammation (Inflammations)
12/2008
1Carcinogenesis
10/2007
1Autoimmune Hypothyroidism
04/2006
1Goiter
01/2005
1Thyroid Neoplasms (Thyroid Cancer)
01/2005
1Neoplasms (Cancer)
01/2005
1Thyroid Nodule (Nodule, Thyroid)
01/2005
1Acromegaly
01/2005
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
12/2002

Drug/Important Bio-Agent (IBA)

10Peptides (Polypeptides)IBA
01/2021 - 09/2008
9ThyroglobulinFDA Link
01/2020 - 01/2002
9InterferonsIBA
01/2019 - 07/2004
9Interferon-alpha (Interferon Alfa)IBA
11/2018 - 06/2003
7HLA-DR3 Antigen (HLA DR3 Antigen)IBA
01/2020 - 07/2002
7HLA-DR Antigens (HLA-DR)IBA
01/2017 - 04/2006
6CytokinesIBA
01/2020 - 07/2013
5Proteins (Proteins, Gene)FDA Link
10/2021 - 12/2008
5Thyrotropin Receptors (Thyrotropin Receptor)IBA
01/2020 - 12/2002
5AntibodiesIBA
06/2013 - 06/2003
4IodineIBA
09/2012 - 06/2003
3Insulin (Novolin)FDA Link
11/2021 - 12/2017
3Arginine (L-Arginine)FDA Link
02/2016 - 07/2010
3AutoantibodiesIBA
11/2015 - 02/2002
3Amino AcidsFDA Link
09/2010 - 09/2008
3AntigensIBA
08/2005 - 07/2002
2cepharanthineIBA
01/2021 - 01/2020
2Monoclonal AntibodiesIBA
01/2021 - 01/2010
2Complementary DNA (cDNA)IBA
01/2020 - 04/2011
2RNA (Ribonucleic Acid)IBA
01/2020 - 12/2017
2Interleukin-6 (Interleukin 6)IBA
12/2017 - 01/2010
2Interleukin-8 (Interleukin 8)IBA
07/2013 - 12/2008
2CTLA-4 AntigenIBA
11/2008 - 01/2007
1VaccinesIBA
11/2021
1dihydrolipoamideIBA
10/2021
1Phosphoglycerate Mutase (Phosphoglyceromutase)IBA
10/2021
1inositol polyphosphate multikinaseIBA
10/2021
1methionine aminopeptidase 2IBA
10/2021
1Immune Checkpoint InhibitorsIBA
03/2021
1Cathepsin HIBA
01/2021
1GlucocorticoidsIBA
08/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020
1AutoantigensIBA
01/2020
1Iodide Peroxidase (Deiodinase)IBA
01/2020
1ChemokinesIBA
01/2020
1transgelinIBA
01/2020
1Viral ProteinsIBA
01/2017
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2017
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
02/2015
1Amiodarone (Amiodarona)FDA LinkGeneric
01/2015
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2015
1Metformin (Glucophage)FDA LinkGeneric
01/2015
1Anti-Arrhythmia AgentsIBA
01/2015
1Lysine (L-Lysine)FDA Link
08/2014
1Histones (Histone)IBA
08/2014
1Antithyroid Agents (Antithyroid Drugs)IBA
06/2013
1Glutamine (L-Glutamine)FDA Link
08/2010
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
08/2010
1Neutral Amino AcidsIBA
07/2010
1Immunologic Factors (Immunomodulators)IBA
01/2010
1Glycoproteins (Glycoprotein)IBA
12/2008
1InterleukinsIBA
03/2008
1Thyroid HormonesIBA
10/2007
1DNA (Deoxyribonucleic Acid)IBA
09/2007
1Messenger RNA (mRNA)IBA
06/2005
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2005
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2005

Therapy/Procedure

7Therapeutics
12/2020 - 04/2006
2Drug Therapy (Chemotherapy)
03/2021 - 01/2010
1Precision Medicine
01/2021
1Immunotherapy
12/2020
1Glycemic Control
10/2020
1Artificial Respiration (Mechanical Ventilation)
08/2020
1Personal Protective Equipment
01/2020
1Drug Tapering
08/2013
1Hematopoietic Stem Cell Transplantation
01/2010